About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Trial In Patients With Advanced Cancer And Leukemia

A Trial In Patients With Advanced Cancer And Leukemia

NCT00878189·10 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

16–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients with advanced cancer that is resistant to standard therapy or for which no standard therapy is available
Patients with acute T cell leukemia/lymphoblastic lymphoma that is resistant to standard therapy or for which no standard therapy is available
Men and women \>16 years old

You may not be if

Prior treatment with a gamma secretase inhibitor for treatment of cancer
Patients taking Tamoxifen
Patients with active graft versus host disease
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness
Patients who are pregnant or breast feeding
Patients with clinical evidence of central nervous system disease

The record

StatusCompleted

PhasePhase 1

Taking part72

StartedJun 2009

UpdatedNov 12, 2019

Conditions

Neoplasms by Histologic Type

Where10

Anschutz Cancer Pavilion
Aurora, Colorado, United States
University of Colorado Denver CTRC
Aurora, Colorado, United States
University of Colorado Hospital
Aurora, Colorado, United States